Internal Medicine

The SURPASS-CVOT trial offers critical data comparing the cardiovascular safety of tirzepatide against dulaglutide in patients … Critical Trial Update: Tirzepatide vs. Dulaglutide for CV RiskRead more

Clinical guidelines recommend using Bisphosphonates for CRPS, but evidence supporting this treatment has been limited. A … Bisphosphonates for CRPS: Are They Safe and Effective?Read more

The landmark Women Informed to Screen Depending on Measures of Risk (WISDOM) randomised clinical trial provides … Is Risk-Based Screening the Future for Breast Cancer?Read more

Patients with HER2-positive early breast cancer and residual invasive disease after neoadjuvant therapy are at high … T-DXd Overthrows T-DM1 for High-Risk HER2+ Breast CancerRead more

The management of Patent Ductus Arteriosus (PDA) in extremely premature infants is a highly controversial topic … New Evidence: Why Expectant PDA Management is Safer for Preterm InfantsRead more

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are highly effective medications for treating type 2 diabetes and obesity. … GLP-1 Agonists & Cancer: The Latest Safety Data for DoctorsRead more

The World Endoscopy Organization (WEO) released a vital international consensus statement on the legal and ethical … Mandatory AI Ethics: What Every Indian Endoscopist Must KnowRead more

Diabetic foot infection (DFI) represents the most frequent cause of diabetes-related hospital admissions worldwide. This complex … DFI Dilemma: Expert Strategies for Diabetic Foot InfectionRead more

Sepsis, a life-threatening organ dysfunction caused by a dysregulated host response to infection, presents a major … Game Changer? ImmunoSep Trial Refines Sepsis Treatment.Read more

Sepsis remains a critical public health issue globally. Furthermore, the condition is highly heterogeneous, making a … Breakthrough: Precision Immunotherapy Improves Sepsis OutcomesRead more